TP53 and hepatocellular carcinoma: To further examine the effects of p53 on cuproptosis in HCC cells, we treated PLC/PRF/5 cells (harboring the p53-R249S mutation) with CP-31398, and accordingly found that CP-31398 treatment upregulated FDX1 expression (Figures 3N, O).